CJC-1295 (No DAC)

Research peptide overview

Overview

CJC-1295 (No DAC) is a synthetic peptide studied as an analog of growth hormone–releasing hormone (GHRH). Unlike the DAC-modified version, it has a shorter half-life and is typically explored in research for its role in pulsatile growth hormone signaling and regulatory pathways.

Research Applications

Preclinical and experimental research has explored CJC-1295 (No DAC) in the following areas:

• Growth hormone release and regulation
• Pulsatile hormone signaling patterns
• Recovery and regenerative biology models
• Sleep-related hormonal activity

These are research areas, not approved therapeutic claims.

Research Overview

Published studies and experimental literature have discussed CJC-1295 (No DAC) in connection with:

• Growth hormone secretion and pituitary signaling
• Hormonal pulsatility and timing dynamics
• Recovery-related biological processes
• Interaction with GHRH receptor pathways

Most evidence is derived from preclinical and controlled experimental models.

Mechanism

In experimental settings, CJC-1295 (No DAC) acts as a GHRH analog, binding to receptors in the pituitary to stimulate growth hormone release. Its shorter half-life allows it to be studied for its role in more natural, pulsatile hormone release patterns.

Research Contexts

CJC-1295 (No DAC) has been studied in experimental contexts such as:

• Growth hormone regulation models
• Hormonal pulsatility research
• Recovery and regenerative studies
• Sleep and circadian rhythm investigations

Product Reference

BioJak CJC-1295 (No DAC)
Lyophilized peptide powder
Standard 6 mL vial format
Multiple concentration options available

Important Notice

This product is intended for research and laboratory use only.
Not for human consumption.
Not intended to diagnose, treat, cure, or prevent any disease.